ArticleBioprocess and biosystems engineering2026
Sustainable biosynthesis of exopolysaccharides derived from agricultural byproducts with effective antioxidant properties.
Article in Bioprocess and biosystems engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Exopolysaccharides (EPS) are natural macromolecular carbohydrates with good functional activity and physiological activities, but their industrial application was limited by high production costs and unclear structure-function relationships. This study developed a circular economy strategy to produce EPS via microbial fermentation using two food processing wastes (cane molasses and soy sauce residue). After optimizing fermentation medium, the waste-based system achieved an EPS yield of 33.06 ± 0.54 g/L. Two heteropolysaccharides-EPS-2 and EPS-3 were successfully isolated and purified. Monosaccharide composition analysis revealed that EPS-2 primarily consisted of arabinose, glucose, and galactose in a ratio of 65.35:20.82:13.83. In contrast, EPS-3 exhibited a more complex profile containing rhamnose (33.54%), galactose (31.62%), fucose (17.93%), arabinose (13.47%), and glucose (3.44%). Notably, EPS-3 demonstrated higher antioxidant activity than EPS-2. This study successfully demonstrates an innovative waste-to-value conversion strategy that not only achieves high-value utilization of discarded resources but also establishes the fundamental theoretical framework for scalable production of renewable biopolymers.
Indexed as
Identifiers
41636829What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.